| First Author | Soroosh P | Year | 2013 |
| Journal | J Exp Med | Volume | 210 |
| Issue | 4 | Pages | 775-88 |
| PubMed ID | 23547101 | Mgi Jnum | J:198198 |
| Mgi Id | MGI:5495849 | Doi | 10.1084/jem.20121849 |
| Citation | Soroosh P, et al. (2013) Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J Exp Med 210(4):775-88 |
| abstractText | Airway tolerance is the usual outcome of inhalation of harmless antigens. Although T cell deletion and anergy are likely components of tolerogenic mechanisms in the lung, increasing evidence indicates that antigen-specific regulatory T cells (inducible Treg cells [iTreg cells]) that express Foxp3 are also critical. Several lung antigen-presenting cells have been suggested to contribute to tolerance, including alveolar macrophages (MOs), classical dendritic cells (DCs), and plasmacytoid DCs, but whether these possess the attributes required to directly promote the development of Foxp3(+) iTreg cells is unclear. Here, we show that lung-resident tissue MOs coexpress TGF-beta and retinal dehydrogenases (RALDH1 and RALDH 2) under steady-state conditions and that their sampling of harmless airborne antigen and presentation to antigen-specific CD4 T cells resulted in the generation of Foxp3(+) Treg cells. Treg cell induction in this model depended on both TGF-beta and retinoic acid. Transfer of the antigen-pulsed tissue MOs into the airways correspondingly prevented the development of asthmatic lung inflammation upon subsequent challenge with antigen. Moreover, exposure of lung tissue MOs to allergens suppressed their ability to generate iTreg cells coincident with blocking airway tolerance. Suppression of Treg cell generation required proteases and TLR-mediated signals. Therefore, lung-resident tissue MOs have regulatory functions, and strategies to target these cells might hold promise for prevention or treatment of allergic asthma. |
